dr. abida on choosing between chemotherapy and targeted agents for patients with prostate cancer
Published 7 years ago • 137 plays • Length 1:31Download video MP4
Download video MP3
Similar videos
-
1:22
dr. abida on genetic testing for prostate cancer
-
1:00
dr. abida on future of hormonal therapy in prostate cancer
-
1:02
dr. oh on choosing ar-targeted therapy versus chemotherapy in mhspc
-
1:36
dr. oh on results of chemotherapy versus arta in prostate cancer
-
0:38
new findings could change the everyday treatment of patients with advanced prostate cancer
-
9:31
promising agents for the treatment of prostate cancer
-
1:19
comparing abiraterone and docetaxel in prostate cancer treatment
-
45:40
esmo24# prostate cancer highlights | reaction from china
-
1:36
dr. oh on ar-targeted therapy and chemotherapy for crpc
-
1:18
dr. abida on the frequency of mutations in prostate cancer
-
2:03
dr. grivas on the role of targeted therapy in prostate cancer
-
9:00
differences between ar-targeted therapy in prostate cancer
-
0:48
dr. kantoff on evolving role of docetaxel in prostate cancer treatment
-
22:01
chemotherapy in #prostatecancer | the psa response & side effects | #markscholzmd #alexscholz
-
3:08
targeted prostate cancer therapies vs. chemotherapy: what’s the difference?
-
44:47
sequencing of chemotherapy and immunotherapy in advanced prostate cancer present and future (2018)
-
1:43
dr. sandler on chemotherapy combination regimens in prostate cancer
-
1:48
targeted therapy vs chemotherapy | targeted therapy for cancer- dr. sreenivass bj | doctors' circle
-
2:29
dr. tagawa on brca2 in patients with prostate cancer receiving psma-targeted radionuclide therapy